Cover Image
市場調查報告書

全球胚胎著床前遺傳基因診斷(PGD)市場未來趨勢

Global Preimplantation Genetic Diagnosis (PGD) Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 317313
出版日期 內容資訊 英文 52 Pages
訂單完成後即時交付
價格
Back to Top
全球胚胎著床前遺傳基因診斷(PGD)市場未來趨勢 Global Preimplantation Genetic Diagnosis (PGD) Market 2014-2018
出版日期: 2014年10月22日 內容資訊: 英文 52 Pages
簡介

所謂胚胎著床前遺傳基因診斷(PGD)檢驗,是為了確認胎兒的遺傳缺陷所作的檢驗。主要用於判斷單一遺傳基因疾病(鐮狀細胞貧血症、囊腫纖維化、亨丁頓舞蹈症、血友病、馬凡氏症、地中海型貧血症、肌肉營養不良症、戴-薩克斯病、脊髓性肌萎縮症等)。PGD檢驗通常是對既知的遺傳病的情況,或妊娠後期,或經歷反復流產的的患者進行。代表性檢驗技術,有PCR(聚合酵素鏈鎖反應)法,FISH(螢光原位雜合反應)法,CGH(比較基因雜合反應)法,SNP(單核苷酸多型性)法等,尤其PCR法最廣受進行。FISH法是適合染色體異常和X連鎖病,非整倍體檢驗的檢驗法。CGH法和SNP法為最尖端的檢驗技術,檢驗、診斷的正確性高。全球胚胎著床前遺傳基因診斷(PGD)市場2013∼2018年的年複合成長率(CAGR)預計達到6.30%。

本報告提供全球的胚胎著床前遺傳基因診斷(以下PGD)市場相關分析、市場概要和結構、市場規模趨勢(今後5年的預測值)、各檢驗技術、各地區的詳細趨勢、推動、阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查、考察。

第1章 摘要整理

第2章 簡稱集

第3章 分析範圍

  • 市場概要
  • 主要的產品與服務

第4章 市場分析技術

  • 市場分析的流程
  • 分析方法

第5章 簡介

第6章 市場環境

  • 市場概況
  • 市場規模與其預測
  • 波特的五力分析

第7章 各技術的市場分析

第8章 各地區的分析

  • 南北美洲的PGD市場
  • 歐洲、中東、非洲(EMEA)地區的PGD市場
  • 亞太地區的PGD市場

第9章 購買標準

第10章 促進市場成長的要素

第11章 推動因素與其影響力

第12章 市場課題

第13章 推動因素、課題的影響力

第14章 市場趨勢

第15章 市場趨勢與其影響

第16章 供應商環境

  • 競爭方案
    • 近幾年的主要趨勢
    • 企業合併、收購(M&A)
  • 市場佔有率分析
  • 其他的著名供應商

第17章 主要供應商分析

  • Genesis Genetics
    • 主要資料
    • 產業概要
    • 服務的分類
    • SWOT分析
  • LabCorp
  • Reproductive Genetics Institute
  • Reprogenetics

第18章 其他相關分析

圖表一覽

目錄
Product Code: IRTNTR4389

About Preimplantation Genetic Diagnosis

Preimplantation genetic diagnosis (PGD) testing involves the identification of genetic defects in embryos. It is performed to identify single gene disorders such as Sickle Cell Anemia, Cystic Fibrosis, Huntington's Disease, Hemophilia, Marfan's Disease, Thalassemia, Muscular Dystrophy, Tay Sachs, and Spinal Muscular Atrophy. PGD tests are generally carried out in cases of a known genetic defect, or in late age pregnancy, or in patients with a history of repeated miscarriages. PCR, FISH, CGH, and SNP are some of the common technologies used in PGD testing with PCR the most widely used. FISH technology is beneficial in the determination of chromosomal abnormalities, X-linked diseases, and aneuploidy screening. CGH and SNP are advanced technologies, which have high accuracy in screening and diagnosis.

TechNavio's analysts forecast the Global Preimplantation Genetic Diagnosis market to grow at a CAGR of 6.30 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Preimplantation Genetic Diagnosis market for the period 2014-2018. To calculate the market size, the report considers revenue generated from sales of PGD services and products including kits and instruments used for PGD.

TechNavio's report, the Global Preimplantation Genetic Diagnosis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Preimplantation Genetic Diagnosis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Genesis Genetics
  • Laboratory Corporation of America
  • Reproductive Genetics Institute
  • Reprogenetics

Other Prominent Vendors

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Illumina
  • Natera
  • PerkinElmer

Market Driver

  • Increasing Rate of Infertility
  • For a full, detailed list, view our report

Market Challenge

  • High Costs of PGD
  • For a full, detailed list, view our report

Market Trend

  • Growing Opportunity for Direct-to-Consumer Genetic Testing
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

08. Geographical Segmentation

  • 08.1. PGD Market in Americas
    • 08.1.1. Market Size and Forecast
  • 08.2. PGD Market in EMEA Region
    • 08.2.1. Market Size and Forecast
  • 08.3. PGD Market in APAC Region
    • 08.3.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Vendor Analysis 2013
  • 16.3. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Genesis Genetics
    • 17.1.1. Key Facts
    • 17.1.2. Business Overview
    • 17.1.3. Service Segmentation
    • 17.1.4. SWOT Analysis
  • 17.2. LabCorp
    • 17.2.1. Key Facts
    • 17.2.2. Business Overview
    • 17.2.3. Business Segmentation
    • 17.2.4. Revenue Segmentation by Business
    • 17.2.5. Revenue Comparison - 2012 and 2013
    • 17.2.6. Key Developments:
    • 17.2.7. SWOT Analysis
  • 17.3. Reproductive Genetics Institute
    • 17.3.1. Key Facts
    • 17.3.2. Business Overview
    • 17.3.3. Service Segmentation
    • 17.3.4. SWOT Analysis
  • 17.4. Reprogenetics
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Service Segmentation
    • 17.4.4. SWOT Analysis

18. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global PGD Market 2013-2018 (US$ million)
  • Exhibit 3: Global PGD Market Segmentation by Technology
  • Exhibit 4: Global PGD Market Segmentation by Geography 2013
  • Exhibit 5: PGD Market in Americas 2013-2018 (US$ million)
  • Exhibit 6: PGD Market in EMEA Region 2013-2018 (US$ million)
  • Exhibit 7: PGD Market in APAC Region 2013-2018 (US$ million)
  • Exhibit 8: Global PGD Market by Geographical Segmentation 2013-2018 (US$ million)
  • Exhibit 9: Global PGD Market by Geographical Segmentation 2013-2018
  • Exhibit 10: Genesis Genetics: Service Segmentation 2013
  • Exhibit 11: Business Segmentation of LabCorp
  • Exhibit 12: Revenue Segmentation of LabCorp 2013
  • Exhibit 13: Revenue Comparison of LabCorp by Business Segments (in US$ millions)
  • Exhibit 14: Reproductive Genetics Institute: Service Segmentation 2013
  • Exhibit 15: Reprogenetics: Service Segmentation 2013
Back to Top